Phase I trial of gemcitabine and vinorelbine in patients with refractory solid tumors: efficacy with minimal toxicity in a geriatric population

被引：0
|
作者：
Radice, P [1 ]
Koletsky, A [1 ]
Greenhawt, M [1 ]
Frankel, C [1 ]
Pearce, P [1 ]
Byrne, C [1 ]
Jahanzeb, M [1 ]
机构：
[1] Interctr Ctr Canc Res Grp, Palm Beach, FL USA
来源：
ANNALS OF ONCOLOGY | 1998年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
130
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [31] Phase I study of gemcitabine, docetaxel, and imatinib in refractory and relapsed solid tumors
    Saraiya, B.
    Karantza-Wadsworth, V.
    Stein, M. N.
    Chugh, R.
    Mehnert, J.
    Moss, R.
    Lin, Y.
    Poplin, E.
    JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [32] Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors
    Saraiya, Biren
    Chugh, Rashmi
    Karantza, Vassiliki
    Mehnert, Janice
    Moss, Rebecca A.
    Savkina, Nelli
    Stein, Mark N.
    Baker, Laurence H.
    Chenevert, Thomas
    Poplin, Elizabeth A.
    INVESTIGATIONAL NEW DRUGS, 2012, 30 (01) : 258 - 265
  • [33] Phase I study of gemcitabine, docetaxel and imatinib in refractory and relapsed solid tumors
    Biren Saraiya
    Rashmi Chugh
    Vassiliki Karantza
    Janice Mehnert
    Rebecca A. Moss
    Nelli Savkina
    Mark N. Stein
    Laurence H. Baker
    Thomas Chenevert
    Elizabeth A. Poplin
    Investigational New Drugs, 2012, 30 : 258 - 265
  • [34] Phase I trial and pharmacokinetics of gemcitabine in children with advanced solid tumors
    Reid, JM
    Qu, WC
    Safgren, SL
    Ames, MM
    Krailo, MD
    Seibel, NL
    Kuttesch, J
    Holcenberg, J
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) : 2445 - 2451
  • [35] Phase I trial of vinflunine and pemetrexed in refractory solid tumors
    Hanna K. Sanoff
    Janine Davies
    Christine Walko
    Larry Buie
    Wing-Keung Chiu
    Anastasia Ivanova
    Bert O’Neil
    Thomas E. Stinchcombe
    Kimberly Keller
    E. Claire Dees
    Investigational New Drugs, 2011, 29 : 131 - 136
  • [36] Phase I trial of vinflunine and pemetrexed in refractory solid tumors
    Sanoff, Hanna K.
    Davies, Janine
    Walko, Christine
    Buie, Larry
    Chiu, Wing-Keung
    Ivanova, Anastasia
    O'Neil, Bert
    Stinchcombe, Thomas E.
    Keller, Kimberly
    Dees, E. Claire
    INVESTIGATIONAL NEW DRUGS, 2011, 29 (01) : 131 - 136
  • [37] A phase I study of the combination of gemcitabine (G), vinorelbine (V) and cisplatin (P) in patients (pts) with solid tumors.
    Schrijvers, D
    Dyck, J
    Van den Brande, J
    Wilmes, P
    Korst, A
    Lardon, F
    Vermorken, J
    ANNALS OF ONCOLOGY, 2000, 11 : 140 - 140
  • [38] Phase I study of a 3-drug combination of gemcitabine, vinorelbine and cisplatin (GVP) in patients (PTS) with solid tumors
    Rasschaert, Marika A.
    Pauwels, Bea
    Corthouts, Bob
    Van den Brande, Jan
    Schrijvers, Dirk
    Vermorken, Jan B.
    ANNALS OF ONCOLOGY, 2006, 17 : 142 - 142
  • [39] Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors
    Sandrine Aspeslagh
    Kunwar Shailubhai
    Rastilav Bahleda
    Anas Gazzah
    Andréa Varga
    Antoine Hollebecque
    Christophe Massard
    Anna Spreafico
    Michele Reni
    Jean-Charles Soria
    Cancer Chemotherapy and Pharmacology, 2017, 79 : 1257 - 1265
  • [40] Phase I dose-escalation study of milciclib in combination with gemcitabine in patients with refractory solid tumors
    Aspeslagh, Sandrine
    Shailubhai, Kunwar
    Bahleda, Rastilav
    Gazzah, Anas
    Varga, Andrea
    Hollebecque, Antoine
    Massard, Christophe
    Spreafico, Anna
    Reni, Michele
    Soria, Jean-Charles
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 79 (06) : 1257 - 1265
12345